ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Pulmonary Disease

Top Pulmonary Disease Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MANOJ MAJMUDAR MD

Pulmonary Disease

26,226

$1.74M

1060
606 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 59%

$66
Average prescription price

Avg: $178

MUHAMMAD AHMED MD

Pulmonary Disease

16,056

$856K

480
370 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 59%

$53
Average prescription price

Avg: $178

SANJAY CHAVDA MD

Pulmonary Disease

11,596

$924K

790
434 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

39%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 59%

$80
Average prescription price

Avg: $178

HARISH SEETHAMRAJU MD

Pulmonary Disease

10,952

$3.55M

238
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

34%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 59%

$324
Average prescription price

Avg: $178

KHEDER KUTMAH M.D.

Pulmonary Disease

10,400

$568K

315
202 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 59%

$55
Average prescription price

Avg: $178

GUL SAHETYA MD

Pulmonary Disease

9,727

$728K

630
405 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 59%

$75
Average prescription price

Avg: $178

RALPH HULLER MD

Pulmonary Disease

8,787

$552K

513
466 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 59%

$63
Average prescription price

Avg: $178

JAMES HANSBROUGH M.D.

Pulmonary Disease

5,116

$756K

483
361 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 59%

$148
Average prescription price

Avg: $178

MAHMOOD ALAM MD

Pulmonary Disease

4,634

$859K

297
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 59%

$185
Average prescription price

Avg: $178

AIJAZ YAZDANI MD

Pulmonary Disease

4,460

$557K

374
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 59%

$125
Average prescription price

Avg: $178

WILLIAM CULBERTSON MD

Pulmonary Disease

4,065

$540K

440
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 59%

$133
Average prescription price

Avg: $178

JOHN MCCONNELL M.D.

Pulmonary Disease

3,955

$3.35M

348
233 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 59%

$846
Average prescription price

Avg: $178

LEWIS DICKINSON M.D.

Pulmonary Disease

3,873

$164K

226
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 59%

$42
Average prescription price

Avg: $178

NEAL MOSER MD

Pulmonary Disease

3,775

$1.6M

362
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 59%

$425
Average prescription price

Avg: $178

WILLIAM BEDWELL MD

Pulmonary Disease

3,611

$722K

451
334 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 59%

$200
Average prescription price

Avg: $178

AQEEL MANDVIWALA MD

Pulmonary Disease

3,156

$446K

333
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 59%

$141
Average prescription price

Avg: $178

HAROLD HALLER MD

Pulmonary Disease

2,946

$716K

373
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 59%

$243
Average prescription price

Avg: $178

RICHARD BAKER MD

Pulmonary Disease

2,935

$429K

350
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 59%

$146
Average prescription price

Avg: $178

SRINIVAS AMMISETTY MD

Pulmonary Disease

2,903

$186K

230
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 59%

$64
Average prescription price

Avg: $178

SAFDAR KHAN M.D.

Pulmonary Disease

2,707

$508K

366
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

85%
prescriptions for brand name drugs

Avg: 59%

$188
Average prescription price

Avg: $178

WILLIAM OBRYAN MD

Pulmonary Disease

2,672

$522K

377
253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

81%
prescriptions for brand name drugs

Avg: 59%

$195
Average prescription price

Avg: $178

TIMOTHY KILLEEN M.D.

Pulmonary Disease

2,597

$853K

409
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 59%

$328
Average prescription price

Avg: $178

ABDI VAEZY MD

Pulmonary Disease

2,579

$317K

228
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 59%

$123
Average prescription price

Avg: $178

AZMI DRAW MD

Pulmonary Disease

2,568

$654K

351
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 59%

$255
Average prescription price

Avg: $178

MARK GRIFFITH M.D.

Pulmonary Disease

2,555

$547K

306
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 59%

$214
Average prescription price

Avg: $178

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank